Castle Biosciences, Inc. (CSTL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Castle Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -46.67x | 40.57x | -10.06x | -9.14x | -34.44x | -123.60x |
| P/B Ratio | 2.39x | 1.62x | 1.48x | 1.54x | 2.62x | 3.06x |
| P/S Ratio | 3.28x | 2.23x | 2.63x | 4.48x | 11.45x | 20.29x |
| Profitability | ||||||
| Gross Margin | 79.4% | 81.9% | 79.5% | 76.6% | 83.2% | 84.5% |
| Operating Margin | -12.4% | 2.6% | -30.9% | -53.2% | -42.6% | -10.4% |
| Net Margin | -7.0% | 5.5% | -26.1% | -49.0% | -33.3% | -16.4% |
| EBITDA Margin | 3.3% | 11.5% | -20.5% | -42.6% | -38.9% | -11.3% |
| Liquidity | ||||||
| Current Ratio | 5.26x | 7.29x | 6.20x | 8.09x | 14.21x | 20.58x |
| Quick Ratio | 5.11x | 7.13x | 6.04x | 7.98x | 14.13x | 20.47x |
| Leverage | ||||||
| Debt/Equity | 0.08x | 0.06x | 0.04x | 0.03x | 0.02x | 0.00x |
YoY = year-over-year change. Source: FMP..